Adcock Ingram Holdings (AIP) Stock Overview

Adcock Ingram Holdings Limited, together with its subsidiaries, engages in the manufacture, marketing, and distribution of healthcare products in South Africa, the United States, Canada, the United Kingdom, rest of Europe, and internationally. It operates through four divisions: Consumer, Over the Counter (OTC), Prescription, and Hospital Products and Services. The company is involved in the sale of various healthcare, personal care, and homecare products through FMCG retailers and corporate pharmacies; OTC medicinal products through corporate and independent pharmacies; branded and generic prescription products, and specialized instrumentation and surgical products; and hospital products in oral solid dosage formulations, syrups, intravenous, and injectable dosage forms. It offers its products for allergies, antiretroviral, baby care, cardiovascular, cannabidiol, central nervous system, colds and flu, cough, dermatology, digestive well-being, energy, feminine hygiene, food and nutrition supplements, gastroenterology, generics, ophthalmology, pain, personal care, respiratory, vitamins, minerals supplements, and women's health. The company also provides renal healthcare services. Adcock Ingram Holdings Limited was founded in 1890 and is headquartered in Midrand, South Africa.